Keywords: Russia, Healthcare Development Plan, Drug importation, Industry

New opportunities in Russia’s pharma market with Healthcare Development Program

Article | 17 December 2009

The recently-announced Russian Healthcare Development Program is likely to cause major structural changes in the country’s pharmaceutical market and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Aventis

Aventis Pharma

Sanofi-Aventis

Novartis

Nycomed

Go to company listing